"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to PMVP. [ FAQ on what and how to ask] For non-PMVP questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. David H. Mack Ph.D.
Headquarter: 400 Alexander Park Drive, Suite 301, Princeton, NJ, United States, 08540
Industry: Biotechnology, Investment Track: -, Employees: 54
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.